Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for LENSAR, Inc. (LNSR : NSDQ)

• Company Description    LENSAR Inc. is a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. LENSAR Inc. is based in Orlando, Florida. Number of Employees: 150

• Price / Volume Information    Yesterday's Closing Price: $5.60 Daily Weekly Monthly 20 Day Moving Average: 96,202 shares Shares Outstanding: 12.28 (millions) Market Capitalization: $68.78 (millions) Beta: 0.87 52 Week High: $13.32 52 Week Low: $5.06 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -8.79% -9.47% 12 Week 7.07% 4.14% Year To Date -51.85% -54.24%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2800 Discovery Drive - Orlando,FL 32826 USA ph: 888-536-7271 fax: - ir.contact@lensar.com http://www.lensar.com

• General Corporate Information    Officers Nicholas T. Curtis - Chief Executive Officer and Director William J. Link - Chairperson of the Board of Directors Thomas R. Staab, II - Chief Financial Officer Todd B. Hammer - Director Elizabeth G. O'Farrell - Director Peer Information LENSAR, Inc. (ABMD) LENSAR, Inc. (DMDS) LENSAR, Inc. (CPWY.) LENSAR, Inc. (EQUR) LENSAR, Inc. (ECIA) LENSAR, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 52634L108 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/06/26 Share - Related Items Shares Outstanding: 12.28 Most Recent Split Date: (:1) Beta: 0.87 Market Capitalization: $68.78 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 6.28 Price/Cash Flow: - Price / Sales: 1.19 EPS Growth vs. Year Ago Period: 100.00% vs. Previous Quarter: 100.00% Sales Growth vs. Year Ago Period: -5.16% vs. Previous Quarter: -16.21% ROE 06/30/26 - - 03/31/26 - -183.19 12/31/25 - - ROA 06/30/26 - - 03/31/26 - 42.26 12/31/25 - -48.11 Current Ratio 06/30/26 - - 03/31/26 - 2.38 12/31/25 - 1.15 Quick Ratio 06/30/26 - - 03/31/26 - 1.08 12/31/25 - 0.62 Operating Margin 06/30/26 - - 03/31/26 - 50.94 12/31/25 - -58.66 Net Margin 06/30/26 - - 03/31/26 - 50.94 12/31/25 - -58.66 Pre-Tax Margin 06/30/26 - - 03/31/26 - 50.94 12/31/25 - -58.66 Book Value 06/30/26 - - 03/31/26 - 0.89 12/31/25 - -2.18 Inventory Turnover 06/30/26 - - 03/31/26 - 1.48 12/31/25 - 1.63 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.00 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - -

Powered by Zacks Investment Research ©